pamidronate has been researched along with imatinib mesylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enjo, F; Kimura, S; Kobayashi, Y; Kuroda, J; Maekawa, T; Ottmann, OG; Segawa, H; Tokuda, H; Ueda, T; Urasaki, Y; Yoshikawa, T | 1 |
| Blasick, TM; Brown, RE; Lun, M; Siegelmann-Danieli, N; Zhang, PL | 1 |
| Beckers, MM; Slee, PH | 1 |
3 other study(ies) available for pamidronate and imatinib mesylate
| Article | Year |
|---|---|
The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Cell Division; Diphosphonates; Drug Synergism; Hematopoietic Stem Cells; HL-60 Cells; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred NOD; Mice, SCID; Monomeric GTP-Binding Proteins; Pamidronate; Piperazines; Protein Prenylation; Pyrimidines; Zoledronic Acid | 2003 |
Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Pamidronate; Piperazines; Pyrazines; Pyrimidines; ras Proteins; Sirolimus | 2004 |
Hypercalcaemia in a patient with a gastrointestinal stromal tumour.
Topics: Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Female; Gastrointestinal Stromal Tumors; Humans; Hypercalcemia; Imatinib Mesylate; Middle Aged; Pamidronate; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines | 2007 |